CNN models based on the combination of CECT with serum biomarkers (CEA and CA 19-9) have shown superiority in the detection of CCA (0.68 vs. 0.45; p = 0.04) [1]. The gene discussed is CEACAM5; the disease is cholangiocarcinoma.